1,390 research outputs found
The risk function approach to profit maximizing estimation in direct mailing
When the parameters of the model describing consumers' reaction to a mailing are known, addresses for a future mailing can be selected in a profit-maximizing way. Usually, these parameters are unknown and are to be estimated. Standard estimation are based on a quadratic loss function. In the present context an alternative loss function is suggested by the mailing company's profit function. This leads to different estimators and higher expected profit.
Value of infliximab (Remicade) in patients with low-risk myelodysplastic syndrome. Final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group
peer reviewedTumor-necrosis factor alpha activity has been correlated to ineffective erythropoiesis in lower risk myelodysplastic syndromes. Infliximab (Remicade) is an anti-tumor-necrosis factor alpha chimeric antibody that is used in the treatment of patients with heumatoid arthritis or Crohn's disease. Forty-six patients with myelodysplastic syndromes and a relatively low risk of developing acute leukemia were included in a randomized phase II study assessing the therapeutic activity of two dosages of infliximab administration (3 mg/kg versus 5 mg/kg). The primary endpoint was the response rate. Responses were observed in 3 of 22 patients (13.1%) randomized to the 3 mg/kg arm, versus 0 of 21 patients randomized in the 5 mg/kg arm. According to the statistical design of the current study, neither of the two infliximab dose schedules tested showed sufficient activity as a single agent in this cohort of unselected patients with early myelodysplastic syndrome
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry
Paroxysmal nocturnal hemoglobinuria is a rare, acquired disease associated with hemolytic anemia, bone marrow failure, thrombosis, and, frequently, poor quality of life. The International PNH Registry is a worldwide, observational, non-interventional study collecting safety, effectiveness, and quality-of-life data from patients with a confirmed paroxysmal nocturnal hemoglobinuria diagnosis or detectable paroxysmal nocturnal hemoglobinuria clone, irrespective of treatment. In addition to evaluating the long-term safety and effectiveness of eculizumab in a global population, the registry aims to improve diagnosis, optimize patient management and outcomes, and enhance the understanding of the natural history of paroxysmal nocturnal hemoglobinuria. Here we report the characteristics of the first 1610 patients enrolled. Median disease duration was 4.6 years. Median granulocyte paroxysmal nocturnal hemoglobinuria clone size was 68.1% (range 0.01-100%). Overall, 16% of patients had a history of thrombotic events and 14% a history of impaired renal function. Therapies included anticoagulation (31%), immunosuppression (19%), and eculizumab (25%). Frequently reported symptoms included fatigue (80%), dyspnea (64%), hemoglobinuria (62%), abdominal pain (44%), and chest pain (33%). Patients suffered from poor quality of life; 23% of patients had been hospitalized due to paroxysmal nocturnal hemoglobinuria-related complications and 17% stated that paroxysmal nocturnal hemoglobinuria was the reason they were not working or were working less. This international registry will provide an ongoing, valuable resource to further the clinical understanding of paroxysmal nocturnal hemoglobinuria
THE DYNAMIC GEOMORPHIC SETTING OF THE LATE PLEISTOCENE HARTLEY MAMMOTH SITE: BURIAL AND SKELETAL PRESERVATION IN A SLUMP-BLOCK DEPRESSION NEAR ABIQUIU, NEW MEXICO
Near Abiquiu in northern New Mexico, the skeletal remains of two mammoths were discovered in the summer of 2014 in the near-surface deposits of a very small alluvial channel. The channel occupies a depression on the backtilted top of a Toreva slump block, a highly unusual setting for a mammoth burial. Geomorphological investigation of the site has provided insight into processes leading to burial and preservation of the remains, as well as local environmental change. Field mapping of sediment sources and LiDAR scans of the contributing slope basin and slump bench provided a map of geomorphic features and surficial geologic deposits. To better understand the geomorphic context of the mammoth remains, termed the ‘Hartley Mammoth,’ six soil pits from the mapped surficial geologic deposits were described in the field. Bedrock and soil samples were analyzed using x-ray fluorescence (XRF), loss on ignition (LOI), x-ray diffraction (XRD) and particle size analysis. Bone collagen from a limb fragment returned a calibrated 14C age for one mammoth of about 33 ka. On the mammoth site slump bench, discontinuous bouldery footslope colluvial deposits show clay films and stage l to l+ carbonate, and were likely deposited shortly following slumping due to failure of oversteepened slump scarps. The deposit surrounding the mammoth remains consists of cobbles and small boulders of sandstone supported by a muddy matrix; this texture strongly suggests that the remains were buried by a debris flow. The debris-flow deposit created a high point in the channel, so that subsequent flow was diverted off the downslope edge of the slump block, protecting the mammoth remains from later erosion. Ped-face carbonate coatings (stage I+) in the debris-flow deposit indicate a greater age than the relatively well-sorted and stratified alluvial deposits in the channel above the debris flow. Following mammoth burial, incremental deposition of finer footslope colluvium continued to the present. Overall, field observations, XRF and XRD analyses indicate that despite the ~33 ka age of the mammoth, very little chemical weathering and limited soil development has occurred in the debris flow and other surficial deposits of apparent late Pleistocene age in this dynamic environment
Non-voting shares in France : an empirical analysis of the voting premium
It is the objective of this paper to determine the voting premium for French shares by comparing the values of voting and non-voting shares, and to analyze the value of the voting rights. The study uses data for 25 French companies which had both types of shares outstanding and traded on the stock exchange during the entire period from 1986 to 1996, or for some time during this interval. The average value of the voting premium is 51,35%.
The paper analyzes the reasons for this surprisingly high value by testing different hypotheses based on dividend differences, the revival) of the voting right, capitalization, shareholder structure, and the share of non-voting capital in total equity capital. The regressions show that the shareholder structure strongly influences the value of the voting premium.
A case study of the attempted takeover of Casino by Promodes shows that investors attach a much higher value to the voting right during relevant situations than at other tomes. Both companies involved had, at the time, two types of shares outstanding and listed. Furthermore the paper shows that non-voting shares have never played an important role in equity finance in France since the companies have different alternatives.
In an international cumparison, France is found to have the second highest voting premium, exceeded only by that of Italy. A probable reason is the low quality of the national accounting standards and the low level of minority shareholder protection.Le but de ce cahier de recherche est l'evaluation du droit de vote en France par une comparaison des actiuns avec et sans droit de vote. L 'analyse est basee sur 25 societes ayant introduit ces deux types d'actions en bourse pendant une partie ou fa totalite des annees 1986-1996, Nous determinons pour cette echantillon l'existence d'une prime moyenne de 51,35% sur les actions sails droit de vote. A travers le test de differentes hypotheses (difference de dividende, reprise du droit de vote, capitalisation, actionnarial et pourcentage du capital sans droil de vote), nous essayons ensuite d'expliquer l'importallce de cette prime. Les regressiuns indiquent que la structure de I 'actionnariat influence jortement la prime. Le cas pratique de l'OPA Promodes sur Casino -ces deux societes ayant introduit deux classes d 'actions en bourse- montre investisseurs donnenl une valeur plus importante au droit de vote pendant des situations critiques. L 'histoire du financement des entreprises montre que les actions sans droit de vote n 'ont jamais joue un role important parce qu'il existe d'autres alternatives moins cheres. Au niveau international, la France presente la 2eme prime fa plus elevee apres l'Italie. L'explication du niveau de ces differents primes est a chercher dans les normes comptables et dans la protection des actionnaires minoritaires
Low-dose Decitabine Vs best supportive care in older patients with AML and low blast counts: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC leukemia cooperative group and german MDS study group
Легионеллез – актуальная проблема медицины транспорта
Приведені результати вивчення циркуляції легионелл на морському і залізничному транспорті. На залізничному транспорті леги онелли знайдені в 6.66% досліджених зразків, на морському - в 3.7% . Дослідження іммуно структури плавсостава і контрольної групи осіб показали достовірну різницю між ними по виявленню легионеллезних антитіл відносно Legionella pneumophila Philadelphia I. Описані три спалахи легионеллеза на морських судах. Приведені дані обґрунтовують необхідність проведення профілактичних заходів відносно легионеллезной інфекції на різних видах транспорту.The results of Legionella circulation on marine vessels and railway transport are given. Legionella was found on railway transport in 6.66% of tests and on marine vessels in 3.7% of cases. The examinations of the crews and control group have shown the significant difference in the presence of legionella's antibody to Legionella pneumophila Philadelphia I in the groups under study. Three outbreaks of Legionnaires' disease have been analyzed. The data obtained promote the necessity of Legionellosis specific
prophylaxis on different transport means
- …
